:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
glp-1 drugs for obesity What's New in Treatment? GLP-1 obesity drugs cleared of
Description
Patients with obesity and Type 2 diabetes had an average weight reduction of 12.3% when including all participants
Semaglutide is another compound with a structure generally similar to liraglutide (GLP-1 with a free fatty acid side chain) but with a much longer half-life, apparently mediated by even tighter coupling to albumin
(5.7) Acute Gallbladder Disease: If cholelithiasis or cholecystitis are suspected, gallbladder studies are indicated
Serious allergic reactions can happen with Saxenda
Saelens, B
Durability of tirzepatide for long-term weight loss and glycemic control are still under study and not yet proven
